ABSTRACT. It has been suggested that modifications of the IGF
of which IGF-I is the best known, on target tissues such as cartilage, bone, and muscle (1) . The amount of hGH secreted over 24 h in short children is asymptotically related to height velocity (2) , and children who are short but growing along or parallel to the 3rd height centile will respond to recombinant hGH treatment (3, 4) . Although these individuals present with normal hGH secretion after standard stimulation tests ( 3 , they often show a phenotypic resemblance to children with IGHD, but are taller. However, we have to emphasize that a normal peak GH concentration after provocative stimulation tests (6) does not exclude physiologic GH deficiency.
We postulated that among the underlying defects there might be abnormalities in the hGH gene cluster or the IGF-I gene because its expression is regulated by hGH (7) and IGF-I plays a pivotal role in normal growth (I). hGH is a 22.000 molecular weight protein consisting of 19 1 amino acid residues. The hGH gene cluster consists of five closely related genes in the 5' (hGH-1, hCS-L, hCS-A, hGH-2, hCS-B) 3', encompassing approximately 66.5 kb on the long arm of chromosome 17 (8) . IGF-I is a 70-amino acid peptide hormone encoded by a gene extending over more than 85 kb on the long arm of chromosome 12 (9, 10) .
In two recent studies, the structure of the IGF-I gene was analyzed in subjects with constitutionally variant stature (1 1, 12) . In one of the studies, a significantly decreased prevalence of one allele of an EcoRV RFLP associated with the IGF-I gene was found in children with CSS (12) , and it was suggested that this might indicate a role for minor abnormalities of the IGF-I gene in CSS.
We have analyzed the IGF-I gene and the hGH gene cluster in children with CSS to determine whether a significant number had a gross structural alteration in these genes or whether CSS was associated with particular RFLP alleles, which might suggest a role for minor structural abnormalities. We also performed IGF-I gene RFLP linkage analysis in 10 families with CSS. A further aim was to assess the priority of searching the IGF-I gene locus in detail for basic molecular defect of CSS, as has been suggested (1 2).
SUBJECTS AND METHODS
Subjects. Fifty-seven prepubertal children [age: 4.1-1 1.9 y; bone age: 2.5-9.5 y; sex: 18 females, 39 males; height standard deviation score: -3.6 to -2.5, mean height velocity standard deviation score: -0.35 (SD 0.25)] with CSS attending the Growth Disorder Clinic at the Middlesex Hospital in London were studied. These included 17 children with CSS (seven females, 10 males) from 10 families. In each of these families, one parent presented with CSS (n = 10; five females, five males; height standard deviation score: -3.4 to -2.5) and came from a family with CSS, whereas the other was of normal height for sex (13) .
We also analyzed eight siblings of normal height for age and sex (13) from these families. The criteria for the categorization of CSS included no demonstrable causes of short stature; in particular, normal body proportion (13, 14) , normal birth weight and length (13) , exclusion of Turner's syndrome in girls, stature -2.5 standard deviation score or less for chronologic age and sex (1 3), a peak hGH level of more than 10 kg/L after standard pharmacologic stimulation and an height velocity within normal range (>25 percentile; >-0.8 SDS). Standard auxologic assessment was performed (15) . No child had evidence of organic disease, psychosocial deprivation, or any eating disorder, and all had normal renal and hepatic function.
Controls were 60 unrelated children with IGHD (criteria are described in ref. 16 ), 50 unrelated normal children of normal height (13) , and 25 adults of normal stature (13), including individuals from three families. Demonstration of normal hGH secretion was undertaken using insulin-induced hypoglycemia. Blood glucose less than 2 mmol/L was achieved in all cases. This test was combined with exogenous administration of thyrotropinreleasing hormone (200 pg) and gonadotropin-releasing hormone (100 pg) to test the remainder of hypothalamo-pituitary axis. All subjects were taken from the British Caucasian population and children of Mediterranean, Asian, African, and Semitic descent were excluded from the study, inasmuch as different allelic frequencies for RFLP have been reported in populations of different racial origin (1 7, 18) .
Hormone assay. Serum hGH concentrations were measured using a Tandem-R Immunoradiometric kit (Hybritech, Nottingham, UK) (19) . The interassay coefficient of variation was 9.2% at 2.0 mU/L and the intraassay coefficient of variation at GH concentrations of 0.7, 2.0, 6.5, and 13.0 mU/L were 10.6, 6.3, 3.5, and 3.25%, respectively. The working standard was HS 244.3 E (NIH, Bethesda, MD), which was recalibrated using the International Reference Preparation of hGH [NIBSC, South Rlimms, UK, code no. 66 (2 17) ]. Blood glucose concentrations were measured using the YSI 23 AM glucose analyzer (Yellow Springs Instrument Co., Yellow Springs, OH).
Gene probes. The recombinant plasmid phu G H 1 contained a nearly full-length (8 16 bp) hGH cDNA insert in the PstI site of PAT 153. The nucleotide sequence of this insert is identical to that of the hGH cDNA clone chGH800/pBR322 (20) . The recombinant plasmid phigflA is a cDNA clone containing the 5' untranslated region, coding region, and part of the 3' untranslated region corresponding to the IGF-IA mRNA (21) . The 8 16-bp PstI insert of phu GH I and a 660-bp EcoRI/BamHI fragment of the phigf 1A were labeled with (a-32P)-deoxycytosine triphosphate (3000 Ci/mmol; New England Nuclear Ltd., Boston, MA) by the random primer method of Feinberg and Vogelstein (22) .
Southern blotting analysis. Genomic DNA was prepared from peripheral blood leucocytes as previously described (I 6). Samples of genomic DNA (10 pg) were digested to completion with restriction enzymes (BamHI, BglI, BglII, EcoRI, EcoRV, HincII, NindIII, MspI, PstI, PvuII) under conditions recommended by the suppliers (Boehringer Mannheim, London, UK). After electrophoresis in 0.5-1.2% (wt/vol) agarose gels, the DNA frag- ments were transferred to nylon membranes (Hybond-N, Amersham International, UK), according to the manufacturer's instructions, prehybridized for at least 3 h at 65°C in 6 x SSPE, 5 X Denhardt's solution, 0.5% SDS, 10% dextran sulphate, 50 pg/ mL denaturated sonicated salmon sperm DNA, and then hybridized overnight at 65°C in prehybridization solution containing lo6 cpm/mL of the hGH or the IGF-I probe. The filters were then washed at 65°C in 2 x SSC, 0.1% SDS (twice for 30 min each) and 0.2 x SSC, 0.1% SDS (twice for 30 min each), respectively, and autoradiographed at -70°C using intensifying screens (23) . Statistics. The x 2 test was used to compare the frequencies of RFLP alleles and the distribution of distinct haplotypes.
RESULTS
Analysis of the IGF-I gene. The pattern of hybridizing fragments generated by BamHI, Bgfl, BglII, EcoRI, HincII, MspI, and PstI were identical for all individuals studied, showing that no gross structural abnormalities of the IGF-I gene were present in children with CSS or IGHD.
The allelic frequencies of the three previously described RFLP of the IGF-I gene (HindIII, PvuII, EcoRV) (10, 18, 24) in unrelated subjects are shown in Table 1 . The HindIII and PvuII RFLP are coinherited (10, 18) . There was no difference in the allelic frequencies between normal children, children with IGHD, and children with CSS.
In addition to this study of unrelated individuals, we studied 10 families with CSS. Of the 10 families studied, six contained heterozygotes for the HindIII/PvuII RFLP (5.2 kb, 4.8 kbl5.1 kb, 4.7 kb) and three contained heterozygotes for the EcoRV RFLP (1 3.0 kb, 1 1.5 kb) (Fig. I ). Of these, with respect to the trait, two families were informative for the HindIII/PvtlII IGF-I gene RFLP and two families were informative for the EcoRV IGF-I RFLP. Linkage analysis excluded the possibility of the IGF-I gene exerting a dominant effect in CSS in these families. The lod score for an assumed dominant inheritance of CSS at 1 % recombination was -2.2 and -1.93 for an assumed recessive inheritance, respectively (25) .
Analysis of the hGH-gene cluster. The frequencies for all five common RFLP of the hGH gene cluster in unrelated subjects with CSS are shown in Table 2 . The frequency of the different alleles in subjects with CSS did not differ from those that we previously described in children with IGHD and children of normal height (16) .
The different hGH gene cluster haplotypes in 10 families with CSS are shown in Table 3 . One parent in each of these 10 families was of normal stature (n = 10) and eight of the children (eight of 25) were of normal height for chronologic age and sex (13) . These 18 subjects are shown as controls in Table 3 . We were unable to include the BglII(B) RFLP in this analysis because of problems in discriminating the different genotypes (16) . The frequency of appearance of each haplotype showed no significant difference between the subjects with CSS and the control group. There was no significant difference between the frequencies of appearance of the haplotypes in the CSS group and in the normal population and children with IGHD. DISCUSSION We used Southern blotting to analyze the structure of the IGF-I gene and the hGH gene cluster in children with CSS. There were no major structural abnormalities of the IGF-I locus in subjects with CSS and/or IGHD. The allelic frequencies for the coinherited HindIII and PvzrII RFLP in the British population (Table I) reported ( 1 2). Our data do not support this finding, inasmuch as we found an identical allelic frequency for the 13.0-kb allele in children with CSS (7%), children of normal height (8%) for age and sex (1 3), and children with IGHD (7%). There is no obvious explanation for the difference in allelic frequencies found in the normal British and French populations. In addition, our linkage data exclude a dominant effect of the IGF-I gene in CSS.
In another study, using ribonuclease protection assay, no common variations in the coding or noncoding regions of the IGF-I gene were found in subjects with CSS (1 I). These data and our findings support the idea that the IGF-I gene is a highly conserved gene and does not play an important part in determining growth failure in individuals with CSS.
Using the hGH gene probe, the presence of 25-kb Hind111 and 3.8-kb BamHI fragments and the absence of an additional Hind111 fragment of 18.3 or 17.4 kb indicates that all subjects with CSS camed all five genes of the hGH cluster. The allelic frequencies of the five common RFLP and the distribution of the different haplotypes did not differ in the CSS, normal, and IGHD groups of children. These data extend the spectrum of growth disorders in which the hGH gene cluster has been studied and enable us to conclude that structural abnormalities of the hGH gene cluster detectable by restriction endonuclease analysis are only very rarely causes for growth failure. f' is the maximum likelihood estimate and its SEM for each haplotype.
